Initiates Coverage on Electromed (NYSE:ELMD) started coverage on shares of Electromed (NYSE:ELMDGet Rating) in a research note issued to investors on Monday. The firm set a “strong-buy” rating on the stock.

Shares of ELMD opened at $11.64 on Monday. The company has a 50-day moving average of $12.31. The stock has a market cap of $99.32 million, a P/E ratio of 44.77 and a beta of 0.59. Electromed has a 52-week low of $10.31 and a 52-week high of $13.85.

About Electromed (Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with's FREE daily email newsletter.